Medication Safety
Voluntary recall issued for Nortrel 7/7/7 - 28 day
Published in Women's Health Weekly, August 7th, 2003
Barr Laboratories, Inc., (BRL) announced that it is initiating a voluntary recall of three lots of its Nortrel 7/7/7 - 28 day (norethindrone and ethinyl estradiol tablets, USP) oral contraceptive product to the pharmacy level and is encouraging women who are currently taking the product to carefully examine their blister cards to confirm that the color-coded tablets are packaged in the proper color sequence.
The first three rows (labeled Start, Week 2, and Week 3) of a properly packaged product contain colored tablets. The last row (labeled Week 4) of a properly packaged product contains white tablets. The recall is being implemented because two individuals have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cardiology
Heart research often not useful to women - Reproductive Medicine
Newly identified biochemical markers improve assessment of endometrium - Alzheimer Disease
Overweight at age 70 increases women's risk of AD - Breast Cancer
Common antioxidant may decrease risk - Menopause
Black cohosh may not be safe alternative therapy for breast cancer patients - Mental Health
Genetic differences partly account for higher incidence of depression in women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
